135 related articles for article (PubMed ID: 33645339)
21. MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.
Paulin FE; O'Neill M; McGregor G; Cassidy A; Ashfield A; Ali CW; Munro AJ; Baker L; Purdie CA; Lane DP; Thompson AM
BMC Cancer; 2008 Oct; 8():281. PubMed ID: 18828900
[TBL] [Abstract][Full Text] [Related]
22. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.
Xue Z; Zhu X; Teng Y
Med Sci Monit; 2016 Sep; 22():3186-90. PubMed ID: 27604213
[TBL] [Abstract][Full Text] [Related]
23. Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women.
Kang S; Wang DJ; Li WS; Wang N; Zhou RM; Sun DL; Duan YN; Li SZ; Li XF; Li Y
Int J Gynecol Cancer; 2009 May; 19(4):572-7. PubMed ID: 19509552
[TBL] [Abstract][Full Text] [Related]
24. Common variant on MDM2 contributes to endometrial cancer susceptibility: evidence based on 7 studies.
Zhao Y; Yang X; Hao X; Pan X; Zhao B; Ma J; Fang J; Zhao M
Tumour Biol; 2014 Aug; 35(8):7555-60. PubMed ID: 24792886
[TBL] [Abstract][Full Text] [Related]
25. Impact of
Wujcicka W; Zając A; Stachowiak G
In Vivo; 2019; 33(3):917-924. PubMed ID: 31028217
[TBL] [Abstract][Full Text] [Related]
26. Association of rs2279744 and rs117039649 promoter polymorphism with the risk of gynecological cancer: A meta-analysis of case-control studies.
Zhang J; Zhang Y; Zhang Z
Medicine (Baltimore); 2018 Jan; 97(2):e9554. PubMed ID: 29480845
[TBL] [Abstract][Full Text] [Related]
27. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
Painter JN; O'Mara TA; Batra J; Cheng T; Lose FA; Dennis J; Michailidou K; Tyrer JP; Ahmed S; Ferguson K; Healey CS; Kaufmann S; Hillman KM; Walpole C; Moya L; Pollock P; Jones A; Howarth K; Martin L; Gorman M; Hodgson S; ; ; De Polanco MM; Sans M; Carracedo A; Castellvi-Bel S; Rojas-Martinez A; Santos E; Teixeira MR; Carvajal-Carmona L; Shu XO; Long J; Zheng W; Xiang YB; ; Montgomery GW; Webb PM; Scott RJ; McEvoy M; Attia J; Holliday E; Martin NG; Nyholt DR; Henders AK; Fasching PA; Hein A; Beckmann MW; Renner SP; Dörk T; Hillemanns P; Dürst M; Runnebaum I; Lambrechts D; Coenegrachts L; Schrauwen S; Amant F; Winterhoff B; Dowdy SC; Goode EL; Teoman A; Salvesen HB; Trovik J; Njolstad TS; Werner HM; Ashton K; Proietto T; Otton G; Tzortzatos G; Mints M; Tham E; ; Hall P; Czene K; Liu J; Li J; Hopper JL; Southey MC; ; Ekici AB; Ruebner M; Johnson N; Peto J; Burwinkel B; Marme F; Brenner H; Dieffenbach AK; Meindl A; Brauch H; ; Lindblom A; Depreeuw J; Moisse M; Chang-Claude J; Rudolph A; Couch FJ; Olson JE; Giles GG; Bruinsma F; Cunningham JM; Fridley BL; Børresen-Dale AL; Kristensen VN; Cox A; Swerdlow AJ; Orr N; Bolla MK; Wang Q; Weber RP; Chen Z; Shah M; French JD; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Edwards SL; Thompson DJ; Spurdle AB
Hum Mol Genet; 2015 Mar; 24(5):1478-92. PubMed ID: 25378557
[TBL] [Abstract][Full Text] [Related]
28. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
[TBL] [Abstract][Full Text] [Related]
29. Murine double-minute 2 homolog single nucleotide polymorphism 309 and the risk of gynecologic cancer.
Ueda M; Yamamoto M; Nunobiki O; Toji E; Sato N; Izuma S; Okamoto Y; Torii K; Noda S
Hum Cell; 2009 May; 22(2):49-54. PubMed ID: 19379464
[TBL] [Abstract][Full Text] [Related]
30. MDM2 and its functional polymorphism SNP309 contribute to the development of esophageal carcinoma.
Xiao FK; Guo S; Yang F; Zhao LS; Wang LD
J Gene Med; 2019 May; 21(5):e3086. PubMed ID: 30861607
[TBL] [Abstract][Full Text] [Related]
31. MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis.
Peng Q; Mo C; Qin A; Lao X; Chen Z; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
J Exp Clin Cancer Res; 2013 Nov; 32(1):85. PubMed ID: 24423195
[TBL] [Abstract][Full Text] [Related]
32. An investigation of relationships between hypoxia-inducible factor-1 alpha gene polymorphisms and ovarian, cervical and endometrial cancers.
Konac E; Onen HI; Metindir J; Alp E; Biri AA; Ekmekci A
Cancer Detect Prev; 2007; 31(2):102-9. PubMed ID: 17418979
[TBL] [Abstract][Full Text] [Related]
33. MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk.
Knappskog S; Lønning PE
Oncotarget; 2011 Mar; 2(3):251-8. PubMed ID: 21436469
[TBL] [Abstract][Full Text] [Related]
34. A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population.
Wang M; Zhang Z; Zhu H; Fu G; Wang S; Wu D; Zhou J; Wei Q; Zhang Z
Clin Cancer Res; 2008 Jun; 14(11):3633-40. PubMed ID: 18519798
[TBL] [Abstract][Full Text] [Related]
35. The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls.
Ma YY; Guan TP; Yao HB; Yu S; Chen LG; Xia YJ; He XJ; Wang HJ; Jiang XT; Tao HQ
PLoS One; 2013; 8(1):e55019. PubMed ID: 23383041
[TBL] [Abstract][Full Text] [Related]
36. MDM2 SNP309 is associated with endometrial cancer risk.
Terry K; McGrath M; Lee IM; Buring J; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):983-6. PubMed ID: 18398041
[TBL] [Abstract][Full Text] [Related]
37. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide association study identifies a possible susceptibility locus for endometrial cancer.
Long J; Zheng W; Xiang YB; Lose F; Thompson D; Tomlinson I; Yu H; Wentzensen N; Lambrechts D; Dörk T; Dubrowinskaja N; Goodman MT; Salvesen HB; Fasching PA; Scott RJ; Delahanty R; Zheng Y; O'Mara T; Healey CS; Hodgson S; Risch H; Yang HP; Amant F; Turmanov N; Schwake A; Lurie G; Trovik J; Beckmann MW; Ashton K; Ji BT; Bao PP; Howarth K; Lu L; Lissowska J; Coenegrachts L; Kaidarova D; Dürst M; Thompson PJ; Krakstad C; Ekici AB; Otton G; Shi J; Zhang B; Gorman M; Brinton L; Coosemans A; Matsuno RK; Halle MK; Hein A; Proietto A; Cai H; Lu W; Dunning A; Easton D; Gao YT; Cai Q; Spurdle AB; Shu XO
Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):980-7. PubMed ID: 22426144
[TBL] [Abstract][Full Text] [Related]
39. Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer.
Lind H; Zienolddiny S; Ekstrøm PO; Skaug V; Haugen A
Int J Cancer; 2006 Aug; 119(3):718-21. PubMed ID: 16496380
[TBL] [Abstract][Full Text] [Related]
40. No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer.
Campbell IG; Eccles DM; Choong DY
Cancer Lett; 2006 Aug; 240(2):195-7. PubMed ID: 16239061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
